Tag:
Resverlogix
Latest Headlines
Latest Headlines
Resverlogix shares crater after cholesterol drug disappoints in PhII
Shares of Resverlogix plunged 39 percent yesterday afternoon after the developer conceded that its cholesterol drug RVX-208 had failed to hit a primary endpoint and raised troubling safety issues in
Resverlogix looks to succeed where Pfizer failed
Canada's Resverlogix is in mid-stage trials for its experimental drug RVX-208. The company, which has no marketed products, is hoping it can achieve the Holy Grail of heart disease drug development:
